BMS-919373

DB15047InvestigationalSmall molecule

BMS-919373 is under investigation in clinical trial NCT02153437 (Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers).

Formula / weight: C₂₅H₂₀N₆O₂S · 468.54 g/mol (avg)
Code names: BMS-919373

Resolves to

Compound

UNIINGB50MQK8NCAS1272353-82-8ChEMBLCHEMBL4094440

Structure

InChIKeyXGKULQQVQWCASY-UHFFFAOYSA-NSMILESNS(=O)(=O)C1=CN=CC(=C1)C1=NC(NCC2=NC=CC=C2)=C2C(C=CC=C2C2=CC=CC=C2)=N1

Targets

P22460KCNA5

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with BMS-919373, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account